What Hedge Funds Think of Valeant as It Tries to Increase Shareholder Value?

Page 2 of 2

Hedge funds were bullish on Valeant Pharmaceuticals Intl Inc (NYSE:VRX) in the second quarter. Of the around 730 elite funds we track, 98 funds owned $22.02 billion of the company’s shares (representing 29.10% of the float) on June 30, versus 104 funds and $20.11 billion respectively at the end of March. Bill Ackman‘s Pershing Square owns 19.47 million shares, while John Paulson’s Paulson & Co owns 9.0 million shares. Jeffrey Ubben’s Valueact Capital owns 14.99 million shares too.

Disclosure: none

Page 2 of 2